Characterisation of #Type2Diabetes subgroups and their association with ethnicity and clinical outcomes: a UK real-world data study using the #EastLondon Database ✅Contact @NELPCKS for help with accessing journal articles @NHS_NELondon @NHS_TNW @NELHCP h
Characterisation of type 2 diabetes subgroups and their association with ethnicity and clinical outcomes: a UK real-world data study using the East London Database https://t.co/jZQxHmM3V4
RT @BJGPjournal: Type 2 diabetes subgroups can be used to stratify treatment and reviews, moving away from a 'one size fits all' care pathw…
RT @BJGPjournal: Type 2 diabetes subgroups can be used to stratify treatment and reviews, moving away from a 'one size fits all' care pathw…
RT @BJGPjournal: Type 2 diabetes subgroups can be used to stratify treatment and reviews, moving away from a 'one size fits all' care pathw…
RT @BJGPjournal: Type 2 diabetes subgroups can be used to stratify treatment and reviews, moving away from a 'one size fits all' care pathw…
Really interesting that 80% cohort were mild age related (although age differed by ethnicity) and severe hyperglycaemic cohort only 10%. So how do we tailor reviews to need and not badge all chronic disease with same by the calendar approach
🎙️ Here's @Ladyroho’s brilliant podcast with the Editor of @BJGPjournal chatting about her identification of type 2 diabetes sub-groups and how they could guide future treatment approaches in primary care. 👉https://t.co/tjpepbVC9d Link to paper https://t
Type 2 diabetes subgroups can be used to stratify treatment and reviews, moving away from a 'one size fits all' care pathway https://t.co/Jct4lL1ae8 Watch the 2-min video @ladyroho @sally_hull @sarah_finer @QMUL_CEG @wellcometrust @lshtm @ehr_lshtm #T2D
RT @QMUL_CEG: @trishgreenhalgh Hi Trish, @Ladyroho & @sally_hull recently published this: https://t.co/jjQt8ElgNK using primary care data t…
@trishgreenhalgh Hi Trish, @Ladyroho & @sally_hull recently published this: https://t.co/jjQt8ElgNK using primary care data to create subgroups for better diabetes management, using CEG's East London Database. May be of interest.
RT @BJGPjournal: T2DM subgroups are strong predictors of clinically important differences in: 🟢 time to onset of vascular disease 🟢 time…
RT @BJGPjournal: Clinically meaningful T2DM subgroups can be identified to stratify primary care pathways & improve healthcare resource all…
RT @BJGPjournal: T2DM subgroups are strong predictors of clinically important differences in: 🟢 time to onset of vascular disease 🟢 time…
Clinically meaningful T2DM subgroups can be identified to stratify primary care pathways & improve healthcare resource allocation https://t.co/Jct4lL1ae8 #diabetes @QMUL_CEG @wellcometrust @lshtm @ehr_lshtm https://t.co/MaGb626EQD
T2DM subgroups are strong predictors of clinically important differences in: 🟢 time to onset of vascular disease 🟢 time to initiation of antidiabetic treatment, and 🟢 attainment of glycaemic control https://t.co/Jct4lL1ae8 @ladyroho #diabetes @sally_